Ugur, O. Et Al. 2002. Ga-66 labeled somatostatin analogue DOTA-DPhe(1)-Tyr(3)-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors. NUCLEAR MEDICINE AND BIOLOGY , vol.29, no.2 , 147-157.

Ugur, O., Kothari, P., Finn, R., Zanzonico, P., Ruan, S., Guenther, I., ... Maecke, H.(2002). Ga-66 labeled somatostatin analogue DOTA-DPhe(1)-Tyr(3)-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors. NUCLEAR MEDICINE AND BIOLOGY , vol.29, no.2, 147-157.

Ugur, ÖMER Et Al. "Ga-66 labeled somatostatin analogue DOTA-DPhe(1)-Tyr(3)-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors," NUCLEAR MEDICINE AND BIOLOGY , vol.29, no.2, 147-157, 2002

Ugur, ÖMER Et Al. "Ga-66 labeled somatostatin analogue DOTA-DPhe(1)-Tyr(3)-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors." NUCLEAR MEDICINE AND BIOLOGY , vol.29, no.2, pp.147-157, 2002

Ugur, O. Et Al. (2002) . "Ga-66 labeled somatostatin analogue DOTA-DPhe(1)-Tyr(3)-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors." NUCLEAR MEDICINE AND BIOLOGY , vol.29, no.2, pp.147-157.

@article{article, author={ÖMER UĞUR Et Al. }, title={Ga-66 labeled somatostatin analogue DOTA-DPhe(1)-Tyr(3)-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors}, journal={NUCLEAR MEDICINE AND BIOLOGY}, year=2002, pages={147-157} }